Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Best match
Most recent
biopharma-reporter
12m
Alto Neuroscience’s depression drug trial fails at phase 2
The negative trial results have tanked the California-based biotech’s market value, with a 70% reduction in share price over ...
biopharma-reporter
4h
The FDA has approved Pfizer’s RSV vaccine Abrysvo for adults aged 18 to 59
The US pharma giant Pfizer recently announced that its respiratory syncytial virus (RSV) vaccine Abrysvo has received FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Workers reject new contract
Settles civil lawsuit
Accused of plagiarism
'Tarzan' star Ron Ely dies
NK troops in RU confirmed
Suffers 'debilitating' stroke
Court orders new sentence
Joins Republican Party
Courthouse attack charges
DOJ warns Musk's PAC?
Pneumococcal vax advice
DNC office shootings arrest
Settles hazardous waste suit
$3.9B storm relief proposal
Timberlake postpones shows
Existing home sales fall
Grizzly bear fatally struck
Oldest person in US dies
Seeks WI ballot exit
Carbon removal firms report
Wins EU antitrust case
G7 Ukraine loan advances
Apple, Goldman Sachs fined
Kentucky lawmaker dies
Israel strikes Lebanese city
Bird flu infects 4 in WA
FDA recalls antidepressant
Yelp disables reviews
Biden says lock up Trump
Hashem Safieddine killed
US fines American Airlines
First father-son duo in NBA
Dodgers legend dies
MO court upholds release
Feedback